Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Type 2 Diabetes, Essential Hypertension Most Common Comorbidities in Patients Who Died from COVID-19
August 19, 2020
- ASKA to Snap Up 24.9% Stake in Vietnam Drug Maker
August 19, 2020
- US FDA Accepts Myovant’s Relugolix Triple Combo for Review in Uterine Fibroids
August 19, 2020
- Novo to Skip August Listing for 1st Oral GLP Agent Rybelsus
August 18, 2020
- Pfizer Japan Takes Generic Contenders to Court over Lyrica Patent
August 18, 2020
- Takeda to Introduce Early Retirement Program for Japan Staffers
August 18, 2020
- Fujifilm to Make Antigen for Novavax’s COVID-19 Vaccine for UK Govt
August 18, 2020
- Japan Pharma Market Down 2.5% in April-June: IQVIA
August 18, 2020
- Solasia Gets Japan Rights to Isofol’s Cancer Drug
August 17, 2020
- Nippon Shinyaku’s DMD Treatment Approved in US
August 17, 2020
- AbbVie Japan Alters Company Rules for Same-Sex, Common-Law Marriages
August 17, 2020
- Fujifilm-Sponsored Avigan Trial to Complete Enrollment on Aug. 16
August 12, 2020
- Biosimilars Showing Accelerated Uptick in Japan, Doctor Fee Incentive as Tailwind
August 12, 2020
- 2 Employees Infected with Coronavirus: Pfizer Japan
August 12, 2020
- Denka to Launch Rapid Antigen Test Kit for COVID-19 on August 13
August 12, 2020
- Xarelto OD Tablets Approved, Specially Developed for Japan: Bayer
August 12, 2020
- Taiho Confirms COVID-19 Cluster at Its Training Center, 8 Test Positive
August 12, 2020
- Takeda Pairs with Novavax to Roll Out Coronavirus Vaccine in Japan, Wins 30 Billion Yen in Govt Funding
August 11, 2020
- Aducanumab Accepted for FDA Review with Priority Tag; Target Date Set for March 7
August 11, 2020
- Otsuka’s 1st Half Pharma Sales Rise 7.6% as 4 Global Brands Fare Well
August 11, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…